Cargando…

Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib

BACKGROUND: This study describes a repeated measures prediction index to identify patients at high risk of ≥ grade 2 hand-foot skin reaction (HFSR) before each week of sorafenib therapy. METHODS: Data from 451 patients who received a sorafenib (400 mg bid) as part of a clinical trial were reviewed (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dranitsaris, G., Vincent, M. D., Yu, J., Huang, L., Fang, F., Lacouture, M. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403729/ https://www.ncbi.nlm.nih.gov/pubmed/22228446 http://dx.doi.org/10.1093/annonc/mdr580

Ejemplares similares

Grade III hand-foot skin reaction induced by sorafenib
por: Chiriac, Anca, et al.
Publicado: (2017)

Sorafenib Induced Hand-Foot Skin Reaction at Low Dose
por: Shah, Vrutika H., et al.
Publicado: (2020)

Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine
por: Dranitsaris, George, et al.
Publicado: (2014)

Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatment
por: Ochi, Masanori, et al.
Publicado: (2021)

As Clinical Markers, Hand-Foot-Skin Reaction and Diarrhea Can Predict Better Outcomes for Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization plus Sorafenib
por: Liu, Lei, et al.
Publicado: (2019)

Regorafenib-associated hand–foot skin reaction: practical advice on diagnosis, prevention, and management
por: McLellan, B., et al.
Publicado: (2015)

Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma
por: Wang, Enxin, et al.
Publicado: (2019)

Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib
por: Jain, Lokesh, et al.
Publicado: (2010)

Validation of the prophylactic efficacy of urea‐based creams on sorafenib‐induced hand‐foot skin reaction in patients with advanced hepatocellular carcinoma: A randomised experiment study
por: Lien, Ru‐Yu, et al.
Publicado: (2021)

Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol
por: Demirkan, Serkan, et al.
Publicado: (2017)

A clinical scoring tool validated with machine learning for predicting severe hand–foot syndrome from sorafenib in hepatocellular carcinoma
por: Abuhelwa, Ahmad Y., et al.
Publicado: (2022)

Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K)
por: Nam, Se Hyun, et al.
Publicado: (2016)

Regorafenib-Induced Hand–Foot Skin Reaction Is More Severe on the Feet Than on the Hands
por: Nonomiya, Yuma, et al.
Publicado: (2019)

s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand–foot skin reaction that can be reversed by nicotinamide
por: Luo, Peihua, et al.
Publicado: (2020)

Sorafenib-induced hand-foot syndrome in a patient of renal cell carcinoma
por: Sil, Amrita, et al.
Publicado: (2014)

Effective prevention of sorafenib-induced hand–foot syndrome by dried-bonito broth
por: Kamimura, Kenya, et al.
Publicado: (2018)

Apatinib-Induced Hand–Foot Skin Reaction in Chinese Patients With Liver Cancer
por: Xia, Hui, et al.
Publicado: (2021)

Hand-Foot Skin Reaction with Sunitinib: A Rare Case Report with Review of Literature
por: Das, Suchibrata, et al.
Publicado: (2020)

A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC
por: Melosky, Barbara L., et al.
Publicado: (2018)

Sorafenib Induced Hand Foot Skin Rash in FLT3 ITD Mutated Acute Myeloid Leukemia-A Case Report and Review of Literature
por: Senapati, Jayastu, et al.
Publicado: (2014)

Efficacy of compound traditional Chinese medicine oil in alleviating regorafenib-induced hand-foot skin reaction
por: Zhang, Liyan, et al.
Publicado: (2021)

Development and Validation of Diagnostic Models for Hand-Foot-and-Mouth Disease in Children
por: Zhuo, Feng, et al.
Publicado: (2021)

Hand-foot syndrome associated with use of sorafenib in a patient with papillary thyroid cancer: a case report
por: Velandia-Carrillo, Carlos, et al.
Publicado: (2014)

Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma
por: Pan, Yu, et al.
Publicado: (2021)

Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer
por: Hofheinz, R-D, et al.
Publicado: (2012)

Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial
por: Nishizawa, Aya, et al.
Publicado: (2023)

Retracted: Development and Validation of Diagnostic Models for Hand-Foot-and-Mouth Disease in Children
por: Markers, Disease
Publicado: (2023)

The Efficacy and Safety of the Shouzu Ning Decoction Treatment for Multi-Kinase Inhibitors-Associated Severe Hand–Foot Skin Reaction
por: Shou, Liumei, et al.
Publicado: (2021)

A case report for severe hand-foot skin reaction caused by chemotherapy with actinomycin D in a patient with oculocutaneous albinism
por: Yan, Shi-Jie, et al.
Publicado: (2019)

A rare adverse reaction of sorafenib
por: Wang, Wenwu
Publicado: (2012)

Allergens in Hand, Foot, and Hand–Foot Eczema: An Intercomparison by Patch Testing
por: Sahana, S, et al.
Publicado: (2021)

What is the additional value of MRI of the foot to the hand in undifferentiated arthritis to predict rheumatoid arthritis development?
por: Dakkak, Y. J., et al.
Publicado: (2019)

The reliability and validity of the Korean version of the foot function index for patients with foot complaints
por: In, Tae-Sung, et al.
Publicado: (2017)

Concurrent Hand-Foot Skin Reaction and Hair Depigmentation With Sunitinib: Report of a Case and Literature Review of Kinase Inhibitors and Blocking Antibodies
por: Bansal, Shuchi, et al.
Publicado: (2014)

Hand Foot Syndrome Has the Strongest Impact on QOL in Skin Toxicities of Chemotherapy
por: Urakawa, Ryuta, et al.
Publicado: (2019)

Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
por: Lacouture, Mario, et al.
Publicado: (2018)

Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
por: Borgia, Francesco, et al.
Publicado: (2017)

Development and validation of quantitative optical index of skin blood content
por: Peng, Yu-Hao, et al.
Publicado: (2022)

Development and validation of a Greek language version of the Manchester Foot Pain and Disability Index
por: Kaoulla, Patricia, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9skfpo0nnhbda27d4t3m71r8pm